October 9 is DAF Day! Use your Donor Advised Fund to help save lives today. Give Now.
Published on: September 15, 2020
American Cancer Society grantee Andras Heczey, MD, is trying to adapt the technique known as CAR T-cell therapy to cure children with neuroblastoma by using natural killer T cells. He's trying the treatment for the first time in children in a phase 1 clinical trial.
Published on: September 1, 2020
American Cancer Society grantee Jennifer Mack, MD, MPH, conducts research to help pediatric oncologists communicate more effectively with their patients' parents to make treatment decisions less stressful.
Published on: October 4, 2017
Alix Seif, MD, MPH, is studying a new type of immunotherapy that could teach the immune system long-term memory. The goal is for the immune system to kill any new leukemia cells for the rest of the child's life.
Published on: September 25, 2017
With the success of the new drug, Kymriah, pediatric oncology researchers are trying to adapt CAR T-cell therapy to treat solid tumors, like neuroblastoma.